Chandigarh, August 2, 2025: To spread awareness on the most advanced medical technologies for the treatment of prostate problems and enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH), the first national operative and observership conference on Rezum and RIRS, “Steam and Stone,” being organised by Fortis Hospital Mohali, commenced at Hotel Taj here today.
The two-day event has been organised following efforts by Dr. Rohit Dadhwal, Consultant – Urology, Andrology and Robotic Surgery. Nearly 100 renowned urologists from across the country, surgeons and other medical professionals are taking part in the event.
Giving information, Dr. Rohit Dadhwal, said, “The workshop aims to spread awareness on Water Vapor Therapy (Rezum) – the latest form of minimal invasive surgical treatment for Prostate – available at Fortis Hospital Mohali.”
He said, “Water vapor therapy (Rezūm) is a painless day-care procedure that is offered to patients who are at high risk or are young and to want to preserve their fertility. The long-term effects are the same as those of a traditional procedure. The procedure itself doesn’t require any cutting of the Prostate tissue, hence there is no bleeding, and there is no pain. The procedure is conducted under local anesthesia and the patient is kept under observation for one hour.”
Dr Dadhwal further, added, “Since BPH (enlarge prostrate) occurs in old age, most of the patients have cardiac and other comorbidities. In such cases like these, patients are on blood-thinning medications, which may lead to high chances of bleeding during the procedure, also multiple diseases and old age increases the peri and post-operative risk. For such patients, this procedure is a blessing.”
“Also, traditional prostate surgeries like TURP or Holep lead to sexual problems like ejaculatory and erectile dysfunction. For young symptomatic patients of BPH, who want to preserve their fertility, this is one of the few treatment options which offers such relief. Long-term data which is available now suggest that the effect of this therapy is the same as that of TURP, but it negates the need of anesthesia and admission,” he further added.
Day-1 of the conference featured a series of live operative sessions, observership demonstrations and interactive panel discussions focused on Rezum therapy for benign prostatic hyperplasia and Retrograde Intrarenal Surgery (RIRS) for kidney stones. The attendees witnessed cutting-edge procedures, discussed clinical outcomes and gained insights into the latest technological innovations that are shaping patient-friendly urological care.
Shedding light on the event, he said, “Modalities like water vapour therapy (Rezum), and Robot-aided Surgery are the future in prostate care. With cutting-edge technology, early resumption of normal activity is possible within a week and tumour control is achieved which was a challenge in open and laparoscopic technique.”
Other key highlights of the conference are, Live Rezum therapy demonstrations showcasing the latest minimally invasive techniques for BPH, RIRS operative sessions illustrating advanced endoscopic management of kidney stones and panel discussions and Q&A sessions on patient selection, procedural nuances, and post-operative care.
The two-day conference, which will conclude on August 3, has paved the way for more advanced surgical demonstrations, expert panels, and interactive discussions in the upcoming sessions of the conference.
About Fortis Healthcare
Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, ~4,750 operational beds (including O&M facilities), and over 400 diagnostics centers (including JVs). The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with a global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs over 23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
